Clinical Trial Overview Dataset: Non-Clinical Research Frameworks for Selective Androgen Receptor Modulators (SARMs

Authors AR-CHEM Research Standards GroupAffiliation: Independent Research Supply & Standards Documentation (UK/EU)Contact: research@your−domainyour-domainyour−domain Description (Zenodo Abstract) This dataset provides a structured overview of non-clinical and pre-clinical research frameworks used in published and registered studies involving Selective Androgen Receptor Modulators (SARMs). The dataset does not contain participant-level data, dosing instructions, or interventional guidance. Its purpose is to support: Literature review and meta-analysis Research design comparison Regulatory and ethical assessment Safe handling and documentation standards for laboratory research compounds All information is derived from publicly available clinical trial registries, peer-reviewed publications, and regulatory summaries, reformatted into a standardised dataset for academic reference. This dataset is provided for research and educational use only, and based only surrounding SARMs in the UK. Keywords (Important for Discovery) Selective Androgen Receptor Modulators SARMs Clinical Trial Overview Preclinical Research Translational Medicine Research Methodology Regulatory Science Non-Clinical Studies Dataset Structure File 1 — sarms_clinical_trial_overview.csv Column Name Description compound_name Common compound identifier used in literature alternative_identifiers Registry or chemical aliases study_type Preclinical / Phase I / Phase II research_context Muscle wasting, bone density, cachexia, etc. study_design Randomised, double-blind, observational model Human / animal / in-vitro primary_endpoint High-level endpoint (e.g. lean mass change) secondary_endpoints Hormonal markers, safety endpoints regulatory_status Investigational / discontinued / completed data_source Registry or journal reference public_registry ClinicalTrials.gov / EU CTR / publication ethical_notes Publicly stated ethics compliance notes Neutral study summary File 2 — methodology_notes.pdf Contents: Scope limitations Inclusion / exclusion criteria for studies Explanation of endpoint categorisation Handling of discontinued or incomplete trials Ethical framing and non-interventional clarification File 3 — safe_handling_and_documentation.md Contents: Research-only designation Storage and stability considerations COA interpretation overview PPE and laboratory handling standards Waste disposal references (No consumer or performance language.)